This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Jul;46(7):1400-1401.

doi: 10.1007/s00259-019-04326-3. Epub 2019 Apr 24.

EANM Focus 1: one small step for two men, one giant leap for a specialty

Stefano Fanti¹, Wim J G Oyen^{2

3}

Affiliations

Affiliations

¹ Medicina Nucleare, Policlinico S. Orsola, University of Bologna, Bologna, Italy. fanti@aosp.bo.it.
² Department of Biomedical Sciences, Humanitas University, Milan, Italy.
³ Department of Radiology & Nuclear Medicine, Rijnstate, Arnhem, The Netherlands.

PMID: 31016331
DOI: 10.1007/s00259-019-04326-3

Editorial

EANM Focus 1: one small step for two men, one giant leap for a specialty

Stefano Fanti et al. Eur J Nucl Med Mol Imaging. 2019 Jul.

. 2019 Jul;46(7):1400-1401.

doi: 10.1007/s00259-019-04326-3. Epub 2019 Apr 24.

Authors

Stefano Fanti¹, Wim J G Oyen^{2

3}

Affiliations

¹ Medicina Nucleare, Policlinico S. Orsola, University of Bologna, Bologna, Italy. fanti@aosp.bo.it.
² Department of Biomedical Sciences, Humanitas University, Milan, Italy.
³ Department of Radiology & Nuclear Medicine, Rijnstate, Arnhem, The Netherlands.

PMID: 31016331
DOI: 10.1007/s00259-019-04326-3

No abstract available

PubMed Disclaimer

Similar articles

Molecular Imaging and Theranostics in Pancreatic Neuroendocrine Tumours: From a Luminous Present to an Even Brighter Future.
Paola M, Mansi L. Paola M, et al. Curr Radiopharm. 2019;12(2):93-95. doi: 10.2174/187447101202190530074002. Curr Radiopharm. 2019. PMID: 31362647
Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG, Vinik AI, OʼDorisio TM, OʼDorisio MS. Harris AG, et al. Pancreas. 2020 May/Jun;49(5):599-603. doi: 10.1097/MPA.0000000000001546. Pancreas. 2020. PMID: 32433395 Free PMC article. No abstract available.
Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs.
Czernin J. Czernin J. J Nucl Med. 2019 Aug;60(8):1037. doi: 10.2967/jnumed.119.233627. J Nucl Med. 2019. PMID: 31371618 No abstract available.
Prostate Cancer Imaging and Therapy: Potential Role of Nanoparticles.
Kilcoyne A, Harisinghani MG, Mahmood U. Kilcoyne A, et al. J Nucl Med. 2016 Oct;57(Suppl 3):105S-110S. doi: 10.2967/jnumed.115.170738. J Nucl Med. 2016. PMID: 27694162 Review.
Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.
Langbein T, Weber WA, Eiber M. Langbein T, et al. J Nucl Med. 2019 Sep;60(Suppl 2):13S-19S. doi: 10.2967/jnumed.118.220566. J Nucl Med. 2019. PMID: 31481583 Review.

See all similar articles

References

1. Lancet Oncol. 2018 Dec;19(12):e696-e708 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Springer